The following is a summary of “Adjunctive Midodrine Therapy for Vasopressor-Dependent Shock in the ICU: A Systematic Review ...
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $197.5, along with a high estimate of $209.00 and a low estimate of $183.00. This current ...